PHK
SURF

Point72 Hong Kong’s Surface Oncology, Inc. Common Stock SURF Stock Holding History

Point72 Hong Kong’s Portfolio SURF Stock Details SURF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-2,508
Closed -$7K – 2538
2022
Q1 		$7K Buy
+2,508
New +$8.79K ﹤0.01% 1650

Other funds holding SURF

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
AVAI
Atlas Venture Associates IX Boston, Massachusetts $11.8M AUM 58.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Point72 Hong Kong's SURF Position: Q2 2022 in Review

Point72 Hong Kong sold out of Surface Oncology, Inc. Common Stock (SURF) in Q2 2022, closing a stake of 2,508 shares — an estimated $7K sold.

Point72 Hong Kong first reported a position in SURF in Q1 2022 and held it in 1 quarter. The position peaked at $7K in Q1 2022. 84 funds tracked by Wall St. Rank hold SURF as of Q2 2022.

  • Point72 Hong Kong reported no remaining Surface Oncology, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Point72 Hong Kong sold 2,508 Surface Oncology, Inc. Common Stock shares in Q2 2022, an estimated $7K.
  • Point72 Hong Kong first reported a position in Surface Oncology, Inc. Common Stock in Q1 2022 and held it in 1 quarter.
  • Point72 Hong Kong's Surface Oncology, Inc. Common Stock position peaked at $7K in Q1 2022.
  • 84 funds tracked by Wall St. Rank held Surface Oncology, Inc. Common Stock as of Q2 2022.

Based on Point72 Hong Kong's 13F filing for Q2 2022, filed 15 Aug 2022.